MAFK and metabolic syndrome: The other 26 eQTLs from the cluster—DENND11, FBXL6, GLIPR1L1, EPCAM, FAM83F, FAM86C2P, LRRC70, LPAR5, MROH5, MYBPHL, OR51M1, OR7E91P, GALNT6, PPM1N, SPINT1, SMIM22, TSPEAR, UBN2, UBE2A, VCX3A, PRB3, ELF4, MAFK, TORA2, CALML6, and MZF1—would be novel eQTLs associated with MetS in PD patients.